Journal profile

Genes, chromosomes & cancer

Publisher: Wiley-Liss
ISSN1045-2257 | 1098-2264 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.21
Citation rate 2.48 415 total citations
h5-index 25 h5 depth signal
Cited share 69.1% 121 of 175
Total citations 415 Citation footprint
Metric signal 2.11 External metric anchor
Self-citation 4.6% 19 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 342
Germany 121
Canada 87
China 78
Japan 73

Citing Fields of Research

Musculoskeletal & Nerve Cancer 309
Oncology 186
Hematology 144
Genetics & Genomics 135
Cytogenetics 92

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 4,383 Articles tracked across the journal lifetime
Indexed publication set 175 121 cited publications
Last 12 months 87 7.3 publications/month
Open access share 33.3% 29 OA publications in the last year
Leading citing country United States 342 citing publications
Leading citing field Musculoskeletal & Nerve Cancer 309 citing publications
Latest tracked publication 9 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1,Sept. 1989-
PubMed
v1n1,Sept. 1989-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Musculoskeletal & Nerve Cancer

Broad Categories

Molecular Biology Neoplasms Musculoskeletal & Nerve Cancer

MeSH Descriptors

Cell Transformation, Neoplastic Chromosome Aberrations Neoplasms

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Jakub Czerwiński, Karolina Miarka‐Walczyk, Zuzanna Urbańska et al.
Primary pericardial SMARCB1 ‐deficient tumors with rhabdoid morphology are exceptionally rare. We present an adult case of a primary SMARCB1 ‐deficient pericardial tumor showing concurrent loss of INI1 ( SMARCB1 ) and BRG1 ( SMARCA4 ) ex...
04
Frédéric Lambert, Rafael Fernandez Carazo, Benjamin Koopmansch et al.
The molecular interpretation of eosinophilic neoplasms harboring t (5;12) may be challenging because cytogenetic breakpoint assignments can suggest a PDGFRB rearrangement without identifying the underlying fusion. We retrospectively inve...
05
Ehsan Taherifard, Alexandre Theron, Erfan Taherifard et al.
Background: Constitutional trisomy 8 mosaicism (CT8M) is a rare chromosomal disorder with poorly characterized cancer risk. This systematic review aimed at summarizing reported cases of malignancy and associated clinical outcomes in indi...
08
Huang‐Pin Shen, Ming‐Yung Lee, Yi‐Ju Lee et al.
Background: Neuroendocrine carcinoma (NEC) of the uterine cervix is a rare, highly aggressive malignancy with a poor prognosis. Expanding upon our previous work, which identified frequent mutations in HER2 , KRAS , and PIK3CA in this dis...
09
Naohiro Makise, Jason Lin, Yuki Nakamura et al.
Pathological diagnosis of sarcoma is challenging. Although high‐throughput sequencing and methylation array aid sarcoma diagnosis and are routine in high‐income countries, access to these genetic/epigenetic analyses in many countries, in...

Bibliographical & Catalog Notes

Title from cover.

Print issues ceased with v. 59 (2020).

Also issued online.

Vol. 12, no. 4 (1995)19950516 Notice published Printed on acid-free paper